Free Trial

Willow Biosciences (WLLW) Competitors

Willow Biosciences logo
C$0.06 +0.01 (+9.09%)
(As of 12/24/2024 01:21 PM ET)

WLLW vs. DB, LABS, CWEB, NRTH, MRV, VM, CTX, FLWR, KHRN, and MPH

Should you be buying Willow Biosciences stock or one of its competitors? The main competitors of Willow Biosciences include Decibel Cannabis (DB), MediPharm Labs (LABS), Charlotte's Web (CWEB), 48North Cannabis (NRTH), Nuvo Pharmaceuticals (MRV), Voyageur Pharmaceuticals (VM), Crescita Therapeutics (CTX), Flowr (FLWR), Khiron Life Sciences (KHRN), and Medicure (MPH). These companies are all part of the "drug manufacturers - specialty & generic" industry.

Willow Biosciences vs.

Willow Biosciences (TSE:WLLW) and Decibel Cannabis (CVE:DB) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their media sentiment, community ranking, institutional ownership, analyst recommendations, dividends, profitability, valuation, risk and earnings.

0.1% of Willow Biosciences shares are owned by institutional investors. Comparatively, 0.8% of Decibel Cannabis shares are owned by institutional investors. 24.3% of Willow Biosciences shares are owned by insiders. Comparatively, 1.1% of Decibel Cannabis shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Decibel Cannabis has higher revenue and earnings than Willow Biosciences. Decibel Cannabis is trading at a lower price-to-earnings ratio than Willow Biosciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Willow BiosciencesC$1.84M4.70-C$8.70M-C$0.06-1.00
Decibel CannabisC$105.60M0.29-C$1.03M-C$0.01-7.50

In the previous week, Willow Biosciences' average media sentiment score of 0.00 equaled Decibel Cannabis'average media sentiment score.

Company Overall Sentiment
Willow Biosciences Neutral
Decibel Cannabis Neutral

Willow Biosciences received 10 more outperform votes than Decibel Cannabis when rated by MarketBeat users. Likewise, 82.35% of users gave Willow Biosciences an outperform vote while only 66.67% of users gave Decibel Cannabis an outperform vote.

CompanyUnderperformOutperform
Willow BiosciencesOutperform Votes
14
82.35%
Underperform Votes
3
17.65%
Decibel CannabisOutperform Votes
4
66.67%
Underperform Votes
2
33.33%

Willow Biosciences has a beta of 1.13, indicating that its share price is 13% more volatile than the S&P 500. Comparatively, Decibel Cannabis has a beta of 1.03, indicating that its share price is 3% more volatile than the S&P 500.

Decibel Cannabis has a consensus price target of C$0.28, indicating a potential upside of 277.78%. Given Decibel Cannabis' stronger consensus rating and higher probable upside, analysts plainly believe Decibel Cannabis is more favorable than Willow Biosciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Willow Biosciences
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Decibel Cannabis
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
3.50

Willow Biosciences has a net margin of 0.00% compared to Decibel Cannabis' net margin of -3.78%. Decibel Cannabis' return on equity of -1.05% beat Willow Biosciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Willow BiosciencesN/A -212.20% -74.79%
Decibel Cannabis -3.78%-1.05%3.04%

Summary

Decibel Cannabis beats Willow Biosciences on 10 of the 17 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

WLLW vs. The Competition

MetricWillow BiosciencesDrug Manufacturers IndustryMedical SectorTSE Exchange
Market CapC$8.65MC$1.18BC$5.23BC$6.12B
Dividend Yield7.35%3.04%5.12%5.39%
P/E Ratio-1.00135.1487.7725.20
Price / Sales4.702,547.121,169.931,283.03
Price / Cash0.8310.2543.2382.73
Price / BookN/A3.094.833.13
Net Income-C$8.70MC$152.21MC$120.76MC$295.04M
7 Day PerformanceN/A1.39%2.49%1.99%
1 Month PerformanceN/A-0.53%17.55%0.28%
1 Year PerformanceN/A100.52%28.51%34.91%

Willow Biosciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
WLLW
Willow Biosciences
N/AC$0.06
+9.1%
N/A-40.0%C$8.65MC$1.84M-1.0019Gap Up
DB
Decibel Cannabis
1.2281 of 5 stars
C$0.08
flat
C$0.28
+277.8%
-44.4%C$30.68MC$105.60M-7.5083,000High Trading Volume
LABS
MediPharm Labs
N/AC$0.06
-7.7%
N/A+8.3%C$24.66MC$37.76M-1.50130
CWEB
Charlotte's Web
N/AC$0.15
-1.7%
N/A-49.1%C$23.23MC$54.55M-0.37164Gap Down
NRTH
48North Cannabis
N/AC$0.07
-6.7%
N/A+0.0%C$15.76MC$18.90M-0.3047
MRV
Nuvo Pharmaceuticals
N/AN/AN/AN/AC$15.38MC$72.42M-19.29N/A
VM
Voyageur Pharmaceuticals
N/AC$0.10
-5.0%
N/A+38.5%C$13.25MN/A-9.50N/AHigh Trading Volume
CTX
Crescita Therapeutics
N/AC$0.59
+7.3%
N/A+31.8%C$11.43MC$16.84M-3.9362Gap Down
High Trading Volume
FLWR
Flowr
N/AC$0.03
flat
N/A+0.0%C$10.66MC$12.92M-0.12186Positive News
KHRN
Khiron Life Sciences
N/AC$0.04
flat
N/A+0.0%C$9.30MC$16.14M-0.24N/AGap Up
MPH
Medicure
N/AC$0.89
-1.1%
N/A-36.4%C$9.29MC$20.93M-3.56N/A

Related Companies and Tools


This page (TSE:WLLW) was last updated on 12/26/2024 by MarketBeat.com Staff
From Our Partners